Novel therapeutic options in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a biologically complex and molecularly and clinically heterogeneous disease, and its incidence is increasing as the population ages. Cytogenetic anomalies and mutation testing remain important prognostic tools for tailoring treatment after induction therapy. Despite m...

Descripción completa

Detalles Bibliográficos
Autores principales: Medinger, Michael, Lengerke, Claudia, Passweg, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061308/
https://www.ncbi.nlm.nih.gov/pubmed/27752467
http://dx.doi.org/10.1016/j.lrr.2016.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061308/
https://www.ncbi.nlm.nih.gov/pubmed/27752467
http://dx.doi.org/10.1016/j.lrr.2016.09.001

Ejemplares similares